相关实验视频

Updated: Jun 26, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

PROTAC:用于治疗乳腺癌的不同点的新型可降解方法

Zhenjie Wang¹, Siyao Che², Zhiqiang Yu³

¹Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, PR China; Office of Drug Clinical Trials, The People's Hospital of Gaozhou, Maoming, 525200, PR China.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

|May 13, 2024

概括

化向化体 (PROTACs) 提供了一种新的方法来降解引起疾病的蛋白质. 本综述总结了PROTAC在乳腺癌治疗方面的进展,针对ER和HER2等关键蛋白质.

科学领域:

生物化学和分子生物学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

化向化体 (PROTACs) 使用无素-蛋白酶体系统进行向蛋白质降解.
乳腺癌是女性的主要癌症,为基于PROTAC的治疗策略提供了重大机会.
目前缺乏专门用于乳腺癌治疗的PROTACs的全面更新.

研究的目的:

为了提供一个综合的概述,最近的研究进展在PROTAC治疗乳腺癌.
要突出 PROTACs 对各种乳腺癌相关的标蛋白的应用.
为未来基于PROTAC的乳腺癌治疗方法的开发提供参考.

主要方法:

在乳腺癌研究中对PROTACs的最新研究的文献综述.
专注于PROTAC开发,针对包括雌激素受体 (ER),BET,CDK,HER2,PARP和EZH2.2在内的关键蛋白质.
汇编和综合与乳腺癌模型中的PROTAC疗效和机制相关的研究结果.

主要成果:

在开发针对关键乳腺癌标的PROTAC方面取得了重大进展.
PROTACs显示出潜在的针对性降解驱动乳腺癌进展的蛋白质的潜力.
讨论了针对ER,HER2和其他关键蛋白质的PROTACs的具体例子.

结论:

PROTAC技术对彻底改变乳腺癌治疗有着巨大的前景.
本次审查巩固了目前的进展,确定了关键目标和治疗策略.
进一步的研究和开发对于将PROTAC转化为临床乳腺癌疗法至关重要.

关键词:

乳腺癌是什么? 乳腺癌是什么?雌激素受体的受体是什么这就是PROTAC.乌比奎丁-蛋白酶体降解

更多相关视频

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...